To explore whether FBXO22 expression is associated with AML subtypes, we analyzed FBXO22 expression by one-way ANOVA followed by Fisher’s LSD test in TCGA-LAML and Beat-AML cohort [30]. The gene discussed is FBXO22; the disease is acute myeloid leukemia.